Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Medicinova Inc (MNOV)

Medicinova Inc (MNOV)
1.4900 x 281 1.5000 x 2
Post-market by (Cboe BZX)
1.4900 -0.0100 (-0.67%) 04/23/25 [NASDAQ]
1.4900 x 281 1.5000 x 2
Post-market 1.4900 unch (unch) 14:49 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4298
Day High
1.5000
Open 1.4800
Previous Close 1.5000 1.5000
Volume 7,100 7,100
Avg Vol 14,825 14,825
Stochastic %K 91.45% 91.45%
Weighted Alpha -13.52 -13.52
5-Day Change +0.0900 (+6.43%) +0.0900 (+6.43%)
52-Week Range 1.1200 - 2.5500 1.1200 - 2.5500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,569
  • Shares Outstanding, K 49,046
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,040 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.75
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.37

Options Overview Details

View History
  • Implied Volatility 271.33% ( -7.77%)
  • Historical Volatility 52.43%
  • IV Percentile 78%
  • IV Rank 39.52%
  • IV High 655.42% on 04/04/25
  • IV Low 20.38% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 40
  • Open Int (30-Day) 403

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +1,665,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +31.86%
on 04/07/25
Period Open: 1.5300
1.5400 -3.25%
on 03/25/25
-0.0400 (-2.61%)
since 03/21/25
3-Month
1.1300 +31.86%
on 04/07/25
Period Open: 1.9300
2.0600 -27.67%
on 01/31/25
-0.4400 (-22.80%)
since 01/23/25
52-Week
1.1200 +33.04%
on 08/12/24
Period Open: 1.3300
2.5500 -41.57%
on 11/12/24
+0.1600 (+12.03%)
since 04/23/24

Most Recent Stories

More News
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025

MNOV : 1.4900 (-0.67%)
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients

MNOV : 1.4900 (-0.67%)
MediciNova, Inc. Announces Interim Analysis Results from COMBAT-ALS Trial of MN-166 at International Symposium on ALS/MND

MediciNova presents interim results from COMBAT-ALS trial of MN-166 for ALS at an international symposium.Quiver AI SummaryMediciNova, Inc. announced that interim analysis results from its Phase 2b/3 COMBAT-ALS...

MNOV : 1.4900 (-0.67%)
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MNOV : 1.4900 (-0.67%)
MediciNova, Inc. Provides Corporate Update and Highlights Ongoing Clinical Trials for MN166 and Other Programs

MediciNova updates shareholders on clinical trials and strategic collaborations for neurodegenerative diseases and inflammatory conditions.Quiver AI SummaryMediciNova, Inc., a biopharmaceutical company...

MNOV : 1.4900 (-0.67%)
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

MNOV : 1.4900 (-0.67%)
MediciNova, Inc. Receives Notice of Allowance for Patent on MN-001 Method to Decrease Triglyceride Synthesis in the Liver

MediciNova announces patent allowance for MN-001, a method to reduce liver triglyceride synthesis, aiding metabolic disorder treatments.Quiver AI SummaryMediciNova, Inc. has announced that it received...

MNOV : 1.4900 (-0.67%)
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

MNOV : 1.4900 (-0.67%)
MediciNova: Q3 Earnings Snapshot

MediciNova: Q3 Earnings Snapshot

MNOV : 1.4900 (-0.67%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 2.42 (+4.31%)
STIM : 4.19 (+2.95%)
PGY : 10.11 (+7.78%)
QSI : 1.1700 (+3.54%)
MNOV : 1.4900 (-0.67%)
AXSM : 104.23 (+0.39%)
VSAT : 8.42 (+3.19%)
ZS : 200.59 (+2.07%)
BTM : 1.4100 (+7.63%)
RVPH : 0.8627 (+13.51%)
SPY : 535.42 (+1.55%)
XBI : 79.10 (+1.88%)

Business Summary

MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies,...

See More

Key Turning Points

3rd Resistance Point 1.5869
2nd Resistance Point 1.5435
1st Resistance Point 1.5167
Last Price 1.4900
1st Support Level 1.4465
2nd Support Level 1.4031
3rd Support Level 1.3763

See More

52-Week High 2.5500
Fibonacci 61.8% 2.0037
Fibonacci 50% 1.8350
Fibonacci 38.2% 1.6663
Last Price 1.4900
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective